IMMUNOMODULATORY RESPONSE TO NEOADJUVANT NIVOLUMAB IN NON-METASTATIC CLEAR CELL RENAL CELL CARCINOMA: RESULTS FROM A PHASE I TRIAL

被引：0
|
作者：
Singla, Nirmish
Nirschl, Thomas
Obradovic, Aleksandar
Shenderov, Eugene
Lombardo, Kara
Liu, Xiaopu
Pons, Alice
Zarif, Jelani
Rowe, Steven
Trock, Bruce
Hammers, Hans
Bivalacqua, Trinity
Pierorazio, Phillip
Deutsch, Julie
Lotan, Tamara
Taube, Janis
Ged, Yasser
Gorin, Michael
Allaf, Mohamad
Drake, Charles
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD43-05
引用
收藏
页码：E1119 / E1120
页数：2
相关论文
共 50 条
  • [41] Case of complete response to neoadjuvant therapy using nivolumab in a patient with metastatic renal cell carcinoma
    Ikarashi, Daiki
    Kato, Yoichiro
    Katagiri, Hirokatsu
    Takahara, Takeshi
    Uesugi, Noriyuki
    Shiomi, Ei
    Sugimura, Jun
    Nitta, Hiroyuki
    Sugai, Tamotsu
    Obara, Wataru
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (06) : 630 - 632
  • [42] Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy
    Carlo, Maria I.
    Attalla, Kyrollis
    Mazaheri, Yousef
    Gupta, Sounak
    Yildirim, Onur
    Murray, Samuel J.
    Coskey, Devyn T.
    Kotecha, Ritesh
    Lee, Chung-Han
    Feldman, Darren R.
    Russo, Paul
    Patil, Sujata
    Motzer, Robert J.
    Coleman, Jonathan A.
    Durack, Jeremy C.
    Chen, Ying-Bei
    Akin, Oguz
    Ari Hakimi, A.
    Voss, Martin H.
    EUROPEAN UROLOGY, 2022, 81 (06) : 570 - 573
  • [43] Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma
    Mano, Roy
    Hakimi, A. Ari
    Zabor, Emily C.
    Bury, Marta A.
    Donati, Olivio F.
    Karlo, Christoph A.
    Bazzi, Wassim M.
    Furberg, Helena
    Russo, Paul
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2014, 8 (9-10): : E675 - E680
  • [44] Integrated therapy (neoadjuvant) for non-metastatic renal cell carcinoma: a prospective randomized placebo-controlled pilot trial
    Pahernik, S.
    Hatiboglu, G.
    Huber, J.
    Huesing, J.
    Hadaschik, B.
    Hohenfellner, M.
    ONKOLOGIE, 2012, 35 : 235 - 235
  • [45] Prognostic significance of modified Glasgow Prognostic Score in patients with non-metastatic clear cell renal cell carcinoma
    Cho, Dae Sung
    Kim, Sun Il
    Choo, Seol Ho
    Jang, Seok Heun
    Ahn, Hyun Soo
    Kim, Se Joong
    SCANDINAVIAN JOURNAL OF UROLOGY, 2016, 50 (03) : 186 - 191
  • [46] Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial (vol 86, pg 90, 2024)
    Fitzgerald, Kelly N.
    Lee, Chung-Han
    Voss, Martin H.
    Carlo, Maria I.
    Knezevic, Andrea
    Peralta, Laura
    Chen, Yingbei
    Lefkowitz, Robert A.
    Shah, Neil J.
    Owens, Colette N.
    Mchugh, Deaglan J.
    Aggen, David H.
    Laccetti, Andrew L.
    Kotecha, Ritesh R.
    Feldman, Darren R.
    Motzer, Robert J.
    EUROPEAN UROLOGY, 2025, 87 (01) : 96 - 96
  • [47] Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial
    Bilen, Mehmet A.
    Vo, BaoHan T.
    Liu, Yuan
    Greenwald, Rachel
    Davarpanah, Amir H.
    Mcguire, Donald
    Shiradkar, Rakesh
    Li, Liping
    Midya, Adhishek
    Nazha, Bassel
    Brown, Jacqueline T.
    Williams, Sierra
    Session, Wilena
    Russler, Greta
    Caulfield, Sarah
    Joshi, Shreyas S.
    Narayan, Vikram M.
    Filson, Christopher P.
    Ogan, Kenneth
    Kucuk, Omer
    Carthon, Bradley Curtis
    Del Balzo, Luke
    Cohen, Athena
    Boyanton, Adriana
    Prokhnevska, Nataliya
    Cardenas, Maria Andrea
    Sobierajska, Ewelina
    Jansen, Caroline S.
    Patil, Dattatraya H.
    Nicaise, Edouard
    Osunkoya, Adeboye O.
    Kissick, Haydn T.
    Master, Viraj A.
    NATURE CANCER, 2025, 6 (03) : 432 - 444
  • [48] A phase I/II trial of pazopanib alternating with bevacizumab in treatment-naive metastatic clear cell renal cell carcinoma (CCRCC) patients: Phase I results.
    George, Saby
    Herbst, Laurie
    Sikorski, Marcus
    Diraddo, Ann Marie
    Azabdaftari, Gissou
    Roche, Charles
    Kauffman, Eric
    Li, Qiang
    Schwaab, Thomas
    Levine, Ellis Glenn
    Pili, Roberto
    Chatta, Gurkamal S.
    Appleman, Leonard Joseph
    Groman, Adrienne
    Parikh, Rahul Atul
    Hutson, Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [49] Renal parenchymal infiltration or micronodular spread in non-metastatic clear cell renal cell carcinoma: Prognostic impact and genomic backgrounds
    Tanaka, H.
    Fukawa, Y.
    Yamamoto, K.
    Tanimoto, K.
    Takemoto, A.
    Hasumi, H.
    Hirakawa, A.
    Ishikawa, Y.
    Fukuda, S.
    Waseda, Y.
    Yoshida, S.
    Yokoyama, M.
    Campbell, S. C.
    Fujii, Y.
    EUROPEAN UROLOGY, 2023, 83 : S668 - S669
  • [50] Nivolumab in metastatic renal cell carcinoma
    Nature Reviews Urology, 2015, 12 (2) : 63 - 63
12345